Ten additional states have joined the Certified Community Behavioral Health Clinic (CCBHC) Medicaid demonstration program, expanding access to comprehensive community-based behavioral health services that meet federal certification standards. The expansion occurs as pending legislation H.R. 1 threatens the demonstration's continued funding. CCBHCs provide integrated behavioral health and physical health screening, crisis services, and care coordination under enhanced Medicaid payment structures. The timing creates uncertainty for managed care organizations with CCBHC network arrangements and for states planning implementation.
Why it mattersMCOs in expansion states must prepare to contract with CCBHCs under specialized payment methodologies while monitoring federal funding risk that could disrupt network adequacy and behavioral health access.
Behavioral Health · Managed Care
Advocates for people with disabilities and older adults warn that federal support for home and community-based services (HCBS) may be weakening, 25 years after the Supreme Court's Olmstead decision established the right to receive long-term care at home rather than in institutions. The concern centers on potential policy changes that could reduce federal backing for community-based care options. This comes as Medicaid HCBS programs have grown substantially, with managed care organizations increasingly responsible for delivering and coordinating these services. Any reduction in federal support would directly affect MCO LTSS programs, reimbursement structures, and member access to community-based alternatives.
Why it mattersA rollback of federal HCBS support would force MCOs administering LTSS programs to navigate reduced funding, increased institutional placement pressure, and potential Olmstead compliance risks.
LTSS · Managed Care
Latham & Watkins LLP published its third June 2026 digest tracking developments in drug pricing policy, including the Medicaid Drug Rebate Program, 340B Program, Medicare reforms, and state-level legislative activity. The digest compiles recent regulatory actions, guidance, and policy changes affecting pharmaceutical pricing and market access. The publication serves as an ongoing reference for tracking federal and state drug pricing policy developments. This tracker does not report a single new event but aggregates multiple developments from the period.
Why it mattersMedicaid managed care organizations with pharmacy benefits must monitor Medicaid Drug Rebate Program changes and 340B policy to manage formularies, capitation rate negotiations, and supplemental rebate agreements with manufacturers.
Pharmacy · Managed Care
The Kaiser Family Foundation maintains an ongoing tracker of monthly Medicaid and CHIP enrollment figures across states. The tracker aggregates enrollment data reported by states and CMS, providing a centralized resource for monitoring program size and trends. It is updated as new monthly data becomes available from state and federal sources. The tracker serves as a reference tool for analyzing enrollment patterns following policy changes such as the end of continuous coverage provisions.
Why it mattersEnrollment trends directly affect capitation revenue, network capacity planning, and care management resource allocation for Medicaid managed care organizations.
Managed Care · CHIP
CMS has finalized rule CMS-0053-F addressing prior authorization processes, but the regulation does not solve the underlying interoperability and standardization problems that have prevented automation. The rule requires electronic submission of prior authorization requests, moving away from fax-based workflows. However, it does not establish the data standardization or system integration needed for true automation. Medicaid managed care organizations will need to implement new electronic workflows while still handling manual review processes, creating a compliance obligation without the operational efficiency gains the industry expected.
Why it mattersMCOs must invest in electronic prior authorization infrastructure to comply with CMS-0053-F while maintaining manual review capacity, increasing administrative costs without delivering the automation-driven savings many organizations anticipated.
Managed Care
U.S. senators are advancing legislation to extend the $35 insulin cost cap beyond Medicare to cover private insurance and uninsured individuals. The Medicare cap, enacted under the Inflation Reduction Act, currently applies only to Medicare Part D beneficiaries. The proposed expansion would affect Medicaid managed care organizations that coordinate care for dual-eligible beneficiaries and states with Medicaid pharmacy carve-ins where commercial insulin pricing dynamics affect beneficiary access. No effective date or legislative timeline is specified in the report.
Why it mattersIf enacted, MCOs managing pharmacy benefits would face new insulin pricing requirements that could affect formulary design, pharmacy network contracts, and coordination with commercial insurers for dual-eligible populations.
Pharmacy · Managed Care
The Government Accountability Office found that HHS has not set near-term, measurable goals for the National Alzheimer's Project despite having long-term objectives like reducing Alzheimer's risk. Without these goals, HHS cannot effectively collect performance data, assess progress across the multi-agency initiative, or communicate results to stakeholders. GAO acknowledged the project has contributed to achievements including FDA-approved disease-modifying treatments and diagnostic advances. The report recommends HHS adopt key performance management practices to better track federal investments spread across multiple agencies through 2035, when the project's current authorization expires.
Why it mattersMedicaid managed care organizations covering long-term services and supports face growing Alzheimer's and dementia caseloads — the population is expected to double by 2050 — and federal performance gaps may limit coordination on risk reduction strategies, care protocols, and workforce planning that could reduce avoidable institutional care costs.
LTSS · Managed Care
Senator Bernie Sanders released internal HHS emails indicating that HHS Secretary Robert F. Kennedy Jr. pressured the CDC to alter vaccine messaging and directed the CDC's vaccine advisory panel to restrict vaccine access. The emails document direct intervention in CDC communications and advisory processes. The release comes amid ongoing scrutiny of the administration's vaccine policy direction and its potential impact on public health programs.
Why it mattersChanges to federal vaccine policy and CDC messaging directly affect Medicaid MCO vaccine coverage requirements, VFC program administration, immunization performance metrics, and member outreach strategies.
Managed Care